These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18941419)

  • 21. Direct-to-consumer genetic testing: a comprehensive view.
    Su P
    Yale J Biol Med; 2013 Sep; 86(3):359-65. PubMed ID: 24058310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests.
    Wade CH; Wilfond BS
    Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):284-92, discussion 293. PubMed ID: 17068807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct-to-consumer genetic testing: perceptions, problems, and policy responses.
    Caulfield T; McGuire AL
    Annu Rev Med; 2012; 63():23-33. PubMed ID: 21888511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third-Party Genetic Interpretation Tools: A Mixed-Methods Study of Consumer Motivation and Behavior.
    Nelson SC; Bowen DJ; Fullerton SM
    Am J Hum Genet; 2019 Jul; 105(1):122-131. PubMed ID: 31204012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in genetic testing: clinician variant interpretation processes and the impact on clinical care.
    Berrios C; Hurley EA; Willig L; Thiffault I; Saunders C; Pastinen T; Goggin K; Farrow E
    Genet Med; 2021 Dec; 23(12):2289-2299. PubMed ID: 34257423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical issues in susceptibility genetic testing for late-onset neurodegenerative diseases.
    Manrique de Lara A; Soto-Gómez L; Núñez-Acosta E; Saruwatari-Zavala G; Rentería ME
    Am J Med Genet B Neuropsychiatr Genet; 2019 Dec; 180(8):609-621. PubMed ID: 30525300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.
    SoRelle JA; Thodeson DM; Arnold S; Gotway G; Park JY
    JAMA Pediatr; 2019 Jan; 173(1):e182302. PubMed ID: 30398534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidance for patients considering direct-to-consumer genetic testing and health professionals involved in their care: development of a practical decision tool.
    Jackson L; Goldsmith L; Skirton H
    Fam Pract; 2014 Jun; 31(3):341-8. PubMed ID: 24473677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New approaches to molecular diagnosis.
    Korf BR; Rehm HL
    JAMA; 2013 Apr; 309(14):1511-21. PubMed ID: 23571590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
    Plon SE; Eccles DM; Easton D; Foulkes WD; Genuardi M; Greenblatt MS; Hogervorst FB; Hoogerbrugge N; Spurdle AB; Tavtigian SV;
    Hum Mutat; 2008 Nov; 29(11):1282-91. PubMed ID: 18951446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.
    Bunnik EM; Schermer MH; Janssens AC
    BMC Med Ethics; 2011 Jun; 12():11. PubMed ID: 21672210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic feedback for psychiatric conditions: Where are we now and where are we going.
    Driver MN; Kuo SI; Dick DM
    Am J Med Genet B Neuropsychiatr Genet; 2020 Oct; 183(7):423-432. PubMed ID: 32812348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health system implications of direct-to-consumer personal genome testing.
    McGuire AL; Burke W
    Public Health Genomics; 2011; 14(1):53-8. PubMed ID: 21071927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Interlaboratory Variation in the Interpretation of Genomic Test Results in Patients With Epilepsy.
    SoRelle JA; Pascual JM; Gotway G; Park JY
    JAMA Netw Open; 2020 Apr; 3(4):e203812. PubMed ID: 32347949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk.
    Speicher MR; Geigl JB; Tomlinson IP
    Lancet Oncol; 2010 Sep; 11(9):890-8. PubMed ID: 20537948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.
    European Society of Human Genetics
    Eur J Hum Genet; 2010 Dec; 18(12):1271-3. PubMed ID: 20736974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic tests obtainable through pharmacies: the good, the bad, and the ugly.
    Patrinos GP; Baker DJ; Al-Mulla F; Vasiliou V; Cooper DN
    Hum Genomics; 2013 Jul; 7(1):17. PubMed ID: 23835256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.